Pharmac
pharmac.govt.nz Imported from official source
New Zealand's medicines funding agency; funding decisions and consultation publications from its own official source.
Publications 32
-
Antiretroviral endorsement issue
Technical issue affecting prescriptions for emtricitabine with tenofovir disoproxil and dolutegravir
Announcement Safety -
Agenda for November 2026 Pharmacology and Therapeutics advisory committee (PTAC) meeting
Information on what the Pharmacology and Therapeutics Advisory Committee (PTAC) will be considering at its upcoming meeting in November 2026.
Announcement Safety -
Agenda for November 2026 Mental Health Advisory Committee meeting
Information on what the Mental Health Advisory Committee will be considering at its upcoming meeting in November 2026.
Announcement -
Improving the assessment of medical devices
Pharmac is strengthening how new and emerging health technologies are assessed, while ensuring the right expert advice is available to inform decision making.
Announcement Safety -
Strengthening the Pharmaceutical Schedule
Pharmac is redeveloping the Pharmaceutical Schedule to ensure it remains sustainable, reliable, and fit for purpose for the health system.
Announcement Safety -
Next stage of Pharmac improvement programme underway
Announcement -
Bringing funded flu vaccines forward for under 5s
Announcement Safety -
Changes to support increased access to Estradiol TDP Mylan amid ongoing Estradot supply constraints
Pharmac has made changes to support increased access to the Estradiol TDP Mylan brand of patches, to make the brand easier and more convenient to use.
Announcement Safety -
Widened access to diabetes medicines to benefit over 30,000 New Zealanders
Pharmac has widened access to four medicines for people with type 2 diabetes.
Announcement Safety -
Agenda for October 2026 Gastrointestinal Advisory Committee meeting
Information on what the Gastrointestinal Advisory Committee will be considering at its upcoming meeting in October 2026.
Announcement -
Agenda for October 2026 Cardiovascular Advisory Committee meeting
Information on what the Cardiovascular Advisory Committee will be considering at its upcoming meeting in October 2026.
Announcement -
Agenda for November 2026 Cancer Treatments (CTAC) meeting
Information on what the Cancer Treatments Advisory Committee (CTAC) will be considering at its upcoming meeting in November 2026.
Announcement -
Wegovy and Mounjaro funding status
Medsafe has approved two new medicines as suitable to support weight management. Pharmac's role is to decide whether medicines will be publicly funded.
-
Agenda for October 2026 Cancer Treatments (CTAC) meeting
Information on what the Cancer Treatments Advisory Committee (CTAC) will be considering at its upcoming meeting in October 2026. This has been rescheduled from September due to availability.
Announcement -
Pharmac makes access to Estradiol TDP Mylan (oestradiol) patches easier for New Zealanders
Pharmac is making it easier for people to access oestradiol treatment, by making it easier and more convenient for people to use the Estradiol TDP Mylan brand of patches.
Announcement Safety -
2025/26 Pharmac Letter of Expectations progress update | July 2026
The Minister identified 13 expectations across three themes for Pharmac in his 2025/26 Letter of Expectations. This report tracks our progress on delivering to these expectations.
Announcement Safety -
Agenda for September 2026 Immunisation Advisory Committee (IAC) meeting
Information on what the Immunisation Advisory Committee (IAC) will be considering at its upcoming meeting in September 2026.
Announcement Safety -
Prioritisation activity in the June quarter
Pharmac’s Prioritisation Update provides the latest information about applications for medicines, vaccines, and related products that we’ve assessed for funding. Proactively releasing this informat...
Announcement Safety -
Widened access to diabetes medicines to benefit over 30,000 New Zealanders
From 1 September, Pharmac will widen access to four funded medicines for people with type 2 diabetes, making them available to over 30,000 more New Zealanders over the next five years.
Announcement Safety -
Pharmac to refresh patient advisory function
Pharmac is refreshing its patient advisory function as part of work to strengthen how patient voices and lived experience inform its decisions.
Announcement Safety -
Pharmac introduces a new vision and strategic priorities
It has been a significant 12 months. We have taken the time to listen to patients, partners, and each other, to shape a new vision for Pharmac: Healthier futures. With you. For you.
Announcement -
New agreement to save hospitals millions
Pharmac has secured an ongoing supply of drug-eluting stents for public hospitals at a great price following a competitive procurement process.
Announcement Safety